Neha Sylvia Walter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Neha Sylvia Walter has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Upma Bagai
3 shared publicationsVarun Gorki
3 shared publications- Upma Bagai
Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, 160014 India
2 shared publications - Jasmeet Kaur
Department of Biophysics, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
1 shared publication - Manninder Kaur
Centre for Stem Cell and Tissue Engineering, Panjab University, Chandigarh, India
1 shared publication - Monika Chauhan
University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160014, India; School of Health Sciences and Technology, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, 248007, India
1 shared publication
Latest Publications
- 8 November 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 11 (18) , 5401-5410
Identification of Potential GSK3α Ligands and Prediction of their Drug-like Properties
Glycogen synthase kinase 3 (GSK3) is a pivotal serine/threonine kinase regulating key process such as glycogen synthase, apoptosis and cell-cycle progression. The enzyme is a significant participant of PI3K/PTEN/AKT/GSK3/mTORC1 pathway and implicated in various human cancers. Of the two isoforms α and β in mammals GSK3β is extensively studied in cancer than GSK3α. The present study demonstrated expression of GSK3Α mRNA to be remarkably associated with poor RFS (Relapse Free Survival) in breast cancer patients using KM plotter (Kaplan-Meier plotter). TMN plot revealed a significant (p<0.0001) difference in GSK3A gene expression among the tumour and normal tissue as determined by Wilcoxon Signed Rank Test using both gene chip and RNA sequence data. ROC analysis also revealed the predictive significance of GSK3Α in patients administered endocrine therapy, anti-HER2 therapy and chemotherapy. Considering the importance of this enzyme, potential GSK3α ligands were also identified by molecular docking and ADMET analysis. Four compounds viz.(+/)-Synephrine, LTURM34, 2-Dehydro-3-deoxy-L-fuconate, 603288-22-8 (LY2090314) were found to target GSK3α with favourable pharmacological properties and were found to be non-toxic. These compounds can further be explored for their potential anticancer activity with GSK3α as the primary target.
- 8 November 2025
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 11 (18) , 5401-5410
Identification of Potential GSK3α Ligands and Prediction of their Drug-like Properties
Glycogen synthase kinase 3 (GSK3) is a pivotal serine/threonine kinase regulating key process such as glycogen synthase, apoptosis and cell-cycle progression. The enzyme is a significant participant of PI3K/PTEN/AKT/GSK3/mTORC1 pathway and implicated in various human cancers. Of the two isoforms α and β in mammals GSK3β is extensively studied in cancer than GSK3α. The present study demonstrated expression of GSK3Α mRNA to be remarkably associated with poor RFS (Relapse Free Survival) in breast cancer patients using KM plotter (Kaplan-Meier plotter). TMN plot revealed a significant (p<0.0001) difference in GSK3A gene expression among the tumour and normal tissue as determined by Wilcoxon Signed Rank Test using both gene chip and RNA sequence data. ROC analysis also revealed the predictive significance of GSK3Α in patients administered endocrine therapy, anti-HER2 therapy and chemotherapy. Considering the importance of this enzyme, potential GSK3α ligands were also identified by molecular docking and ADMET analysis. Four compounds viz.(+/)-Synephrine, LTURM34, 2-Dehydro-3-deoxy-L-fuconate, 603288-22-8 (LY2090314) were found to target GSK3α with favourable pharmacological properties and were found to be non-toxic. These compounds can further be explored for their potential anticancer activity with GSK3α as the primary target.
- 24 July 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 184, 1194-1204
Antimalarial efficacy of Sonchus brachyotus D.C (Asteraceace) used in traditional herbal medicine
- 24 July 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 184, 1194-1204
Antimalarial efficacy of Sonchus brachyotus D.C (Asteraceace) used in traditional herbal medicine
- 13 March 2025
- Published by Springer Nature in The Protein Journal
- Vol. 44 (2) , 147-161
Endoplasmic Reticulum Stress: Implications in Diseases
Endoplasmic reticulum (ER) is a specialized organelle that plays a significant role in cellular function. The major functions of ER include protein synthesis and transport, folding of proteins, biosynthesis of lipids, calcium (Ca2+) storage, and redox balance. The loss of ER integrity results in the induction of ER stress within the cell due to the accumulation of unfolded, improperly folded proteins or changes in Ca2+ metabolism and redox balance of organelle. This ER stress commences the Unfolded Protein Response (UPR) that serves to counteract the ER stress via three sensors inositol requiring protein–1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor–6 (ATF6) that serve to establish ER homeostasis and alleviates ER stress. Severe ER dysfunction ultimately results in the induction of apoptosis. Increasing shreds of evidence suggest the implication of ER stress in the development and progression of several diseases viz. tuberculosis, malaria, Alzheimer’s disease, Parkinson’s disease, diabetes, and cancer. Activation of ER stress can be beneficial for treating some diseases while inhibiting the process can be useful in others. A deeper understanding of these pathways can provide key insights in designing novel therapeutics to treat these diseases.
- 13 March 2025
- Published by Springer Nature in The Protein Journal
- Vol. 44 (2) , 147-161
Endoplasmic Reticulum Stress: Implications in Diseases
Endoplasmic reticulum (ER) is a specialized organelle that plays a significant role in cellular function. The major functions of ER include protein synthesis and transport, folding of proteins, biosynthesis of lipids, calcium (Ca2+) storage, and redox balance. The loss of ER integrity results in the induction of ER stress within the cell due to the accumulation of unfolded, improperly folded proteins or changes in Ca2+ metabolism and redox balance of organelle. This ER stress commences the Unfolded Protein Response (UPR) that serves to counteract the ER stress via three sensors inositol requiring protein–1 (IRE1), protein kinase RNA-like ER kinase (PERK), and activating transcription factor–6 (ATF6) that serve to establish ER homeostasis and alleviates ER stress. Severe ER dysfunction ultimately results in the induction of apoptosis. Increasing shreds of evidence suggest the implication of ER stress in the development and progression of several diseases viz. tuberculosis, malaria, Alzheimer’s disease, Parkinson’s disease, diabetes, and cancer. Activation of ER stress can be beneficial for treating some diseases while inhibiting the process can be useful in others. A deeper understanding of these pathways can provide key insights in designing novel therapeutics to treat these diseases.
- 1 November 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 280, 114417
Ethanol extract of Bergenia ciliata (Haw.) Sternb. (rhizome) impedes the propagation of the malaria parasite
- 1 November 2021
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 280, 114417
Ethanol extract of Bergenia ciliata (Haw.) Sternb. (rhizome) impedes the propagation of the malaria parasite
- 1 January 2020
- Published by Medknow in Journal of Vector Borne Diseases
- Vol. 57 (3) , 204-212
Antiplasmodial potential of Thalictrum foliolosum (Ranunculaceae) against lethal murine malaria
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society
- 1 January 2020
- Published by Medknow in Journal of Vector Borne Diseases
- Vol. 57 (3) , 204-212
Antiplasmodial potential of Thalictrum foliolosum (Ranunculaceae) against lethal murine malaria
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society
- Open Access
- 10 January 2016
- Published by Sciencedomain International in British Microbiology Research Journal
- Vol. 17 (6) , 1-10
Antimalarial Efficacy of Bergenia ciliata (Saxifragaceae) Leaf Extract In vitro against Plasmodium falciparum and In vivo against Plasmodium berghei
Aim: The traditional medicinal plant Bergenia ciliata was used to evaluate its antiplasmodial activity against Plasmodium falciparum in vitro and preventive and curative activity against Plasmodium berghei in vivo. The safety of the ethanolic leaf extract of Bergenia ciliata (ELEBC) to the liver and kidney functions of the rodent host was also tested. Place and Duration of the Study: Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, India, between October 2014 to November 2015. Methodology: The in vitro antiplasmodial activity of the ELEBC against both chloroquine-resistant (RKL-9) and sensitive (MRC-2) strains of P. falciparum was assessed by using the WHO method. The cytotoxicity of the extract against human cancer and normal cell lines was tested by MTT assay. The in vivo repository and curative efficacy of the extract against P. berghei were tested using the Peter’s method and modified method of Ryley and Peters respectively. The biochemical assays were performed as per standard methods. Results: ELEBC exhibited considerable inhibitory activity against both RKL-9 and MRC-2 strains of P. falciparum with IC50 of 6.4 µg/ml and 1000 µg/ml and selectivity index (SI) >10. Maximum chemosuppression of 74.45% and 91.96% was observed on day 7 at a concentration of 1000 mg/kg (repository activity) and 250 mg/kg (curative activity), respectively. 83.33% survival of mice was observed in G6 (750 mg/kg) while in all other ELEBC treated groups 50% survival was recorded on day 28 of study in the curative test. Hepatic function (SGOT, SGPT, ALP and bilirubin) and renal function biomarkers (creatinine and urea) in serum were observed to be significantly (P< 0.0005) lower as compared to the infected control (G2). Conclusions: ELEBC possesses considerable antimalarial activity against both sensitive and resistant strains of P. falciparum. It also exhibits significant efficacy as a preventive and curative remedy against the disease without any side effects on hepatic and renal functions of the rodent host.
- 10 January 2016
- Published by Sciencedomain International in British Microbiology Research Journal
- Vol. 17 (6) , 1-10
Open AccessAntimalarial Efficacy of Bergenia ciliata (Saxifragaceae) Leaf Extract In vitro against Plasmodium falciparum and In vivo against Plasmodium berghei
Aim: The traditional medicinal plant Bergenia ciliata was used to evaluate its antiplasmodial activity against Plasmodium falciparum in vitro and preventive and curative activity against Plasmodium berghei in vivo. The safety of the ethanolic leaf extract of Bergenia ciliata (ELEBC) to the liver and kidney functions of the rodent host was also tested. Place and Duration of the Study: Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, India, between October 2014 to November 2015. Methodology: The in vitro antiplasmodial activity of the ELEBC against both chloroquine-resistant (RKL-9) and sensitive (MRC-2) strains of P. falciparum was assessed by using the WHO method. The cytotoxicity of the extract against human cancer and normal cell lines was tested by MTT assay. The in vivo repository and curative efficacy of the extract against P. berghei were tested using the Peter’s method and modified method of Ryley and Peters respectively. The biochemical assays were performed as per standard methods. Results: ELEBC exhibited considerable inhibitory activity against both RKL-9 and MRC-2 strains of P. falciparum with IC50 of 6.4 µg/ml and 1000 µg/ml and selectivity index (SI) >10. Maximum chemosuppression of 74.45% and 91.96% was observed on day 7 at a concentration of 1000 mg/kg (repository activity) and 250 mg/kg (curative activity), respectively. 83.33% survival of mice was observed in G6 (750 mg/kg) while in all other ELEBC treated groups 50% survival was recorded on day 28 of study in the curative test. Hepatic function (SGOT, SGPT, ALP and bilirubin) and renal function biomarkers (creatinine and urea) in serum were observed to be significantly (P< 0.0005) lower as compared to the infected control (G2). Conclusions: ELEBC possesses considerable antimalarial activity against both sensitive and resistant strains of P. falciparum. It also exhibits significant efficacy as a preventive and curative remedy against the disease without any side effects on hepatic and renal functions of the rodent host.
- 23 June 2013
- Published by Springer Nature in Parasitology Research
- Vol. 112 (9) , 3123-3128
Antimalarial activity of Bergenia ciliata (Haw.) Sternb. against Plasmodium berghei
The emergence of resistance against most of the drugs in current use against malaria has aggravated the disease burden in endemic regions. Several plants species have been used for treatment of malaria in traditional/cultural health systems. Bergenia ciliata, used traditionally for treatment of fever by local communities in the Himalayan Region, was evaluated for its plausible role as an antimalarial. Phytochemical screening of the ethanolic leaf extract of B. ciliata (ELEBC) revealed the presence of phenols, flavonoids, steroids and diterpenes. The extract showed good in vitro antiplasmodial activity, with an IC50 5 g/kg, which is considered toxicologically safe for oral administration. When tested in vivo, different concentrations of the extract (250 to 1,000 mg/kg) exhibited considerable chemosuppression on day 7, in a dose-dependent manner. Maximum chemosuppression was observed to be 87.50 % at 1,000 mg/kg. Administration of ELEBC (750 and 1,000 mg/kg) significantly (p < 0.0005) enhanced the mean survival time of mice in comparison to infected control, which exhibited a mean survival time of 8.6 ± 1.5 days. Study reports presence of considerable in vitro and in vivo antimalarial activity in ethanolic leaf extract of B. ciliata for first time. Hence, the ethnopharmacological usage of the plant for treating fever is confirmed with experimental evidence.
- 23 June 2013
- Published by Springer Nature in Parasitology Research
- Vol. 112 (9) , 3123-3128
Antimalarial activity of Bergenia ciliata (Haw.) Sternb. against Plasmodium berghei
The emergence of resistance against most of the drugs in current use against malaria has aggravated the disease burden in endemic regions. Several plants species have been used for treatment of malaria in traditional/cultural health systems. Bergenia ciliata, used traditionally for treatment of fever by local communities in the Himalayan Region, was evaluated for its plausible role as an antimalarial. Phytochemical screening of the ethanolic leaf extract of B. ciliata (ELEBC) revealed the presence of phenols, flavonoids, steroids and diterpenes. The extract showed good in vitro antiplasmodial activity, with an IC50 5 g/kg, which is considered toxicologically safe for oral administration. When tested in vivo, different concentrations of the extract (250 to 1,000 mg/kg) exhibited considerable chemosuppression on day 7, in a dose-dependent manner. Maximum chemosuppression was observed to be 87.50 % at 1,000 mg/kg. Administration of ELEBC (750 and 1,000 mg/kg) significantly (p < 0.0005) enhanced the mean survival time of mice in comparison to infected control, which exhibited a mean survival time of 8.6 ± 1.5 days. Study reports presence of considerable in vitro and in vivo antimalarial activity in ethanolic leaf extract of B. ciliata for first time. Hence, the ethnopharmacological usage of the plant for treating fever is confirmed with experimental evidence.